Experimental in Medical Technology
Navigation Links
Experimental in Medical Technology
... cravings. These results were presented at the experimental Biology 2009 conference in New Orleans.
... initiatives going forward."
About experimental Biology Conference
experimental Biology is a multi-society, interdisciplinary, ...
... the company in the development of the recommended experimental protocols to ensure their alignment with the ... to participation by the FDA in the development of experimental protocols to resume TBI clinical trials in the ... FDA will participate in the development of the experimental protocols, that the planned studies will provide ...
... stem cell transplant can be prevented through an experimental therapeutic strategy in which patients receive ... clinically relevant bleeding. In this study, the experimental strategy was compared with a traditional ... to 10/nL. The researchers concluded that the experimental strategy was both cost effective and safe in this ...
... expand the depth, breadth, and complexity of experimental research approaches aimed at understanding and ... and duration, further extending experimental variation, design, and control. Taken together, ... significantly extending the breadth and depth of experimental protocols, as well as enabling high throughput ...
... has become aware of preliminary data from an investigator-initiated experimental study of the effects of Epoetin alfa in patients with acute ischemic ... indications and dosing recommendations. This investigator-initiated experimental study was designed and conducted by an investigator in Europe. Ortho ...
... cytotoxic agents as well as with newer targeted therapies in preclinical experimental tumor models. Brostallicin binds covalently to DNA within the DNA minor ... or radiotherapy. The EORTC has the aim to facilitate the passage of experimental discoveries into state-of-the-art treatment by keeping to a minimum the ...
... BOSTON, April 10 /PRNewswire/ -- Data from experimental work on the use of organs from cardiac arrested donors will be presented ... clinical updates on non-heart-beating lung donors, and also exciting new experimental work on the possible use of hearts from cardiac-arrested donors," said ...
... activity, and has demonstrated synergism in combination with standard cytotoxic agents as well as with newer targeted therapies, in preclinical experimental tumor models. Brostallicin binds covalently to DNA within the DNA minor groove, interfering with DNA division and leading to tumor cell death. More ...
... edition in an article titled: A Selective Inhibitor of the Immunoproteasome Subunit LMP7 Blocks Cytokine Production and Attenuates Progression of experimental Arthritis . The authors of the article included members of the laboratory of Dr. Marcus Groettrup at the University of Constance (Konstanz, Germany) ...
... improvements in the signs and symptoms of psoriatic arthritis through two years of treatment," said Iain B. McInnes, MD, PhD, FRCP, Professor of experimental Medicine, University of Glasgow , study investigator. "These findings demonstrate the promise and utility of golimumab in treating both the joint ...
... /PRNewswire/ -- Paloma Pharmaceuticals, Inc. presented "Palomid 529, An Inhibitor of the Akt/mTOR Pathway Reduces Photoreceptor Cell Death Following experimental Retinal Detachment", today at the annual meeting of the Association for Research in Vision and Ophthalmology 2009 (ARVO 2009), This study, presented ...
... C-reactive protein in overweight and obese men and women, presented by one of the study researchers, Rose M Giordano, Ph.D. on April 19, 2009 at the experimental Biology meeting held in New Orleans, La. (Logo: http://www.newscom.com/cgi-bin/prnh/20090417/DC01034LOGO ) An immerging body of ...
... at AACR Monday April 20, 2009 9:30 am - 1:00 pm; Minisymposium Novel Molecular Targets / Targeting Cell Death Pathways; experimental and Molecular Therapeutics 12 Room 405-407, Colorado Convention Center 9:40am-9:55am #1984 Btk is a Novel Therapeutic Target to Treat Large ...
... devices. PEAK Surgical's pulsed plasma-mediated discharges and electrode insulation techniques were originally invented at the Hansen experimental Physics Laboratory and Department of Ophthalmology at Stanford University and developed by PEAK Surgical. About PEAK Surgical, Inc. PEAK ...
... to develop, commercialize and manufacture the LAIV technology from Australian company BioDiem, which had acquired these rights from the Institute of experimental Medicine in St. Petersburg, Russian Federation. SCH 900795 could offer several improvements over most current vaccines such as single-dose intranasal ...
... With the success of this program, the next step is a phase 3 trial where hundreds of patients would be enrolled and treated. Due to the experimental features of this clinical trial, some portions of the study may not be covered by health insurance. As a not-for-profit, Aurora Health Care 's ...
... nutriceutical mixture mimics gene expression of long-term caloric restriction in mouse heart. Barger JL, Kayo T, Pugh TD, Prolla TA, Weindruch R. experimental Gerontology 2008 Sep; 43(9):859-66. *This statement has not been evaluated by the Food and Drug Administration. This product is not intended to ...
... the company in the development of the recommended experimental protocols to ensure their alignment with the ... to participation by the FDA in the development of experimental protocols to resume TBI clinical trials in the ... FDA will participate in the development of the experimental protocols, that the planned studies will provide ...
... stem cell transplant can be prevented through an experimental therapeutic strategy in which patients receive ... clinically relevant bleeding. In this study, the experimental strategy was compared with a traditional ... to 10/nL. The researchers concluded that the experimental strategy was both cost effective and safe in this ...
... expand the depth, breadth, and complexity of experimental research approaches aimed at understanding and ... and duration, further extending experimental variation, design, and control. Taken together, ... significantly extending the breadth and depth of experimental protocols, as well as enabling high throughput ...
ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
... response rate in the CoFactor/5-FU/Avastin(R) experimental arm compared to a 31.8% objective response rate ... and 4.8% progressive disease rate in the CoFactor experimental arm compared to a 38.6% stable disease rate and ... in this study, with 6 patients on the CoFactor experimental arm and 4 patients on the leucovorin control ...New Therapy Enlists Immune System to Boost Cure Rate in a Childhood Cancer
... -- A multicenter research team has announced encouraging results for an experimental therapy using elements of the body's immune system to improve cure rates ... expected after early results showed the benefits of immunotherapy. "This experimental immunotherapy is poised to become part of the new standard of care for ...Getting More From Whole-Transcript Microarrays
... splicing from the Gene platform in certain circumstances at no additional experimental cost. We, therefore, provide added value to their collected data." ... a distinct pattern. However, we believe it could be useful in a variety of experimental settings." FIRMAGene can be applied to human, mouse and rat samples, for ...University of California Los Angeles Selects Velos eResearch
... areas, including: Developing new cancer therapies; providing the best in experimental and traditional treatments; and expertly guiding and training the next ... year and conducting hundreds of clinical trials, providing the latest in experimental cancer treatments. About David Geffen School ...Pistachios Offer Protective Benefits Against Heart Disease, Type II Diabetes and Obesity
... Research Presented at experimental Biology 2009 Reveals Cardiovascular and Glycemic Control Benefits of ... other snack food choices, according to research presented this week at experimental Biology 2009 in New Orleans. Researchers from UCLA and the University ...Genes Identified That Enhance Tumor Cell Sensitivity to CTI's Cancer Drug Brostallicin
... "contexts of vulnerability" - that enhance the anti-tumor response to the experimental drug candidate brostallicin, at the 2009 American Association for Cancer ... cytotoxic agents as well as with newer targeted therapies in preclinical experimental tumor models. Brostallicin binds covalently to DNA within the DNA minor ...Cylene to Present Advances in its Oral Inhibitor of CK2 at AACR Annual Meeting
... small molecule inhibitor of protein kinase CK2: Phase I initiated - experimental and Molecular Therapeutics 34, Abstract 4660 Tuesday, April 21, ... of p21 in vitro and in vivo: Implications for biomarker development - experimental and Molecular Therapeutics 37, Minisymposium, Abstract 4768 About ...... has become aware of preliminary data from an investigator-initiated experimental study of the effects of Epoetin alfa in patients with acute ischemic ... indications and dosing recommendations. This investigator-initiated experimental study was designed and conducted by an investigator in Europe. Ortho ...
... cytotoxic agents as well as with newer targeted therapies in preclinical experimental tumor models. Brostallicin binds covalently to DNA within the DNA minor ... or radiotherapy. The EORTC has the aim to facilitate the passage of experimental discoveries into state-of-the-art treatment by keeping to a minimum the ...
Molecular Discoveries Shed Light on Liver Cancer -- Hepatocellular Carcinoma (HCC)
... Genomics improves our ability to target experimental cancer treatments A promising new drug is in hand, and more are on ... we know which patients can be selected for response to particular experimental therapies." Scientists are continuing their search for the genes that ...Preclinical Study Shows CTI's Brostallicin's Cancer-Killing Ability Based on Genetic Profiling
... presented data from a preclinical study demonstrating that the Company's experimental drug candidate, brostallicin, killed colon and ovarian cancer cells ... cytotoxic agents as well as with newer targeted therapies in preclinical experimental tumor models. Brostallicin binds covalently to DNA within the DNA minor ...New Gene Discovery Suggests Which Patients CTI's Brostallicin May Benefit
... gene products involved in brostallicin response. RNA interference is an experimental technique that allows for the targeted reductions of gene expression. A ... cytotoxic agents as well as with newer targeted therapies in preclinical experimental tumor models. Brostallicin binds covalently to DNA within the DNA minor ...... BOSTON, April 10 /PRNewswire/ -- Data from experimental work on the use of organs from cardiac arrested donors will be presented ... clinical updates on non-heart-beating lung donors, and also exciting new experimental work on the possible use of hearts from cardiac-arrested donors," said ...
Tart Cherries May Reduce Inflammation, Lower Risk for Type 2 Diabetes & Heart Disease
... The study was presented by University of Michigan researchers today at the experimental Biology annual meeting. As science continues to reveal inflammation may be ... Diets Reduce Abdominal Obesity and Inflammation in Zucker Fatty Rats. experimental Biology 2008 702.7, Seymour EM, Urcuyo-Llanes D, Lewis SK, Kirakosyan A, ...Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology
... we have tested -- without the need for delivery reagents that can skew experimental results. With Dharmacon Accell siRNA and our Dharmacon SMARTvector shRNA ... saves researchers significant time in their laboratories and avoids the experimental variability caused by toxicity and off-target effects of conventional ...ARUP Laboratories Applauds FDA's Decision on the Value of KRAS-Mutation Testing in Colorectal Cancer
... clinics. ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Clinical & experimental Pathology(R). Further information on ARUP Laboratories can be found at www.aruplab.com . ...Project Zero Delay Accelerates Drug's Path to Clinical Trial
... /PRNewswire-FirstCall/ -- A phase I clinical trial enrolled its first patient only two days after U.S. Food and Drug Administration clearance of the experimental drug for a first-in-human cancer trial, a milestone that normally takes three to six months. Investigators from The University of Texas M. D. ...British Woman Celebrates a Year of Living Cancer-Free
... of tumor-activated natural killer (TaNK) cells as a treatment for leukemia. Her doctors at the Royal Free Hospital in London recommended this experimental therapy after two years of traditional treatments, including chemotherapy and a bone marrow transplant, failed to keep her in remission. Ms. Scott ...... activity, and has demonstrated synergism in combination with standard cytotoxic agents as well as with newer targeted therapies, in preclinical experimental tumor models. Brostallicin binds covalently to DNA within the DNA minor groove, interfering with DNA division and leading to tumor cell death. More ...
New Bisphenol A Study Is of Very Limited Relevance to Human Health
... Institute of Environmental Health Sciences (NIEHS) -- conduct studies that involve injection of laboratory animals with bisphenol A (BPA). This experimental technique has recently been acknowledged by the NIEHS to have very limited value for assessing human health effects since people are orally exposed ...... edition in an article titled: A Selective Inhibitor of the Immunoproteasome Subunit LMP7 Blocks Cytokine Production and Attenuates Progression of experimental Arthritis . The authors of the article included members of the laboratory of Dr. Marcus Groettrup at the University of Constance (Konstanz, Germany) ...
... improvements in the signs and symptoms of psoriatic arthritis through two years of treatment," said Iain B. McInnes, MD, PhD, FRCP, Professor of experimental Medicine, University of Glasgow , study investigator. "These findings demonstrate the promise and utility of golimumab in treating both the joint ...
... /PRNewswire/ -- Paloma Pharmaceuticals, Inc. presented "Palomid 529, An Inhibitor of the Akt/mTOR Pathway Reduces Photoreceptor Cell Death Following experimental Retinal Detachment", today at the annual meeting of the Association for Research in Vision and Ophthalmology 2009 (ARVO 2009), This study, presented ...
Brain Training Improves Memory and Attention and the Effects Last
... I remember what I need at the store," Ms. Allen said. "And I almost never walk into a room and forget why anymore." "The changes we saw in the experimental group were remarkable - and significantly larger than the gains in the control group," said Dr. Zelinski, PhD. "From a researcher's point of view, ...Prostate Cancer Immunotherapy Significantly Prolongs Survival in Men With Advanced Prostate Cancer
... during late-breaking session at AUA Annual Scientific Meeting CHICAGO, April 28 /PRNewswire-USNewswire/ -- Sipuleucel-T (Provenge), an experimental immunotherapy improved survival in men with metastatic disease, according to new results to be presented April 28 at the American Urological ...Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference
... Biologicals with support from the Malaria Vaccine Initiative of PATH (Program for Appropriate Technology in Health), is the first of 70 experimental malaria vaccines, most in early pre-clinical testing, to move into a Phase III clinical trial. The trial, which is expected to take three years, is ...... C-reactive protein in overweight and obese men and women, presented by one of the study researchers, Rose M Giordano, Ph.D. on April 19, 2009 at the experimental Biology meeting held in New Orleans, La. (Logo: http://www.newscom.com/cgi-bin/prnh/20090417/DC01034LOGO ) An immerging body of ...
Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference
... researchers discovered that when an FDA-approved cancer treatment typically used to treat cutaneous T-cell lymphoma was administered before a novel experimental antitumor agent -- which works best in breast cancers expressing the estrogen receptor (ER) -- estrogen receptors were reinstated in ...... at AACR Monday April 20, 2009 9:30 am - 1:00 pm; Minisymposium Novel Molecular Targets / Targeting Cell Death Pathways; experimental and Molecular Therapeutics 12 Room 405-407, Colorado Convention Center 9:40am-9:55am #1984 Btk is a Novel Therapeutic Target to Treat Large ...
... devices. PEAK Surgical's pulsed plasma-mediated discharges and electrode insulation techniques were originally invented at the Hansen experimental Physics Laboratory and Department of Ophthalmology at Stanford University and developed by PEAK Surgical. About PEAK Surgical, Inc. PEAK ...
... to develop, commercialize and manufacture the LAIV technology from Australian company BioDiem, which had acquired these rights from the Institute of experimental Medicine in St. Petersburg, Russian Federation. SCH 900795 could offer several improvements over most current vaccines such as single-dose intranasal ...
... With the success of this program, the next step is a phase 3 trial where hundreds of patients would be enrolled and treated. Due to the experimental features of this clinical trial, some portions of the study may not be covered by health insurance. As a not-for-profit, Aurora Health Care 's ...
Novagali Pharma Presents Results of its Innovative Latanoprost Formulation for Glaucoma
... vivo toxicity assay" at the 9th Scientific Meeting of the Association for Ocular Pharmacology and Therapeutics (AOPT) held in Salzburg, Austria. The experimental work has been performed in collaboration with Professor Christophe Baudouin from the Quinze-Vingts National Ophthalmology Hospital and Science ...... nutriceutical mixture mimics gene expression of long-term caloric restriction in mouse heart. Barger JL, Kayo T, Pugh TD, Prolla TA, Weindruch R. experimental Gerontology 2008 Sep; 43(9):859-66. *This statement has not been evaluated by the Food and Drug Administration. This product is not intended to ...
Pfizer Contributes Critical Data to URMC Drug Safety Initiative
... Medical Center (URMC) with a unique set of electrocardiographic data that will help researchers develop new methods to ensure the safety of experimental drugs. This is the first time a major pharmaceutical company has agreed to publicly share anonymous data from one of its drug safety trials, ...EpiDerm's Skin Irritation Test Fully Validated in European Union
... world-wide to comply with new European Union (EU) REACH legislation as well as the EU directive on the protection and welfare of animals used for experimental and other scientific purposes. This directive (EU 86/609) prohibits the use of animals in experiments if a validated alternative is available. ...Other ContentsdegeneracydeletiondeletiondeletiondeletiondeletiondenaturedenaturedenaturingdenaturingdenaturingdendritesdendritesdendritesdendriticdendriticdendriticdendriticdendriticOther TagsGestation
(Date:11/26/2009)...ed deer have been caught in the hunters, sights fo...than decorative. They are lethal weapons that stag...The University of York, UK, has been intrigued by ...century and has become fascinated by the mechanica...laboration with Tomas Landete-Castillejos at the U...
(Date:11/26/2009)... are the bare essentials of life, the indispensabl...survive on its own? Can we describe the molecular ...ganism functions as a system? These are just some ...between the European Molecular Biology Laboratory ...egulacio Genmica (CRG) in Barcelona, Spain, set ou...
(Date:11/25/2009)...lives. In addition to mammalian immune systems tha...ed bacteriophages, viruses that kill half the bact... and another class of microorganisms called archae...s deep-sea volcanic vents) manage just fine, thank... system that helps protect them from many viruses ...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Nationwide Relocation Services Support Breast Cancer Awareness 61210 1Nationwide Relocation Services Support Breast Cancer Awareness 61210 2Nationwide Relocation Services Support Breast Cancer Awareness 61210 3SourceMedical Earns Cardinal Health Innovation Award 61207 1SourceMedical Earns Cardinal Health Innovation Award 61207 2Fresh Throne Eco Friendly Bathroom Spray Celebrates Launch by Donating to Salvation Army 61204 1Fresh Throne Eco Friendly Bathroom Spray Celebrates Launch by Donating to Salvation Army 61204 2(Date:11/27/2009)... XenaCare Holdings has announced that it has beco... one of the largest nonprofit organizations dedica...ion. , Delray Beach, FL (.... (OTCBB: XCHO), a company specializing in the mar...are products, has announced today that is has beco...
(Date:11/27/2009)...nprecedented medical, economic burdens, study pred...) -- The number of people with diabetes in the Uni...years, a new study predicts. , That would bring...th the disease, up from 23.7 million today. , , ... diabetes will triple, the study also warns, risin...
(Date:11/27/2009)... Voyant Health™ announced today that Spectr...s TraumaCad Enterprise orthopedic templating solut... (PRWEB) November 27, 2009...trum Health (Grand Rapids, Michigan) has licensed ...ution and its TraumaCad Extend workflow solution, ...
(Date:11/27/2009)... Specialist manufacturers who use medical load ce...ions of dollars by bringing in technology partner ...mbers of pro-active medical manufacturers are call...age of their projects, ensuring that progress will...r potentially outdated technology. , ...
(Date:11/26/2009)...v. 27 With cold and flu season upo... practices to control the spread of infections and... only to keep ourselves healthy, but to avoid tran...ty, RN, MS, CIC (certified in infection-control), ...ional health at Hospital for Special Surgery (HSS)...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4[0] XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation [0] Diabetes Cases Expected to Double in 25 Years[0] Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend[0] Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells[1] Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use
GastrinomaGastritisGastroenterologyGastroesophagealGastroparesisGastroschisisGeneralizedGenitaliaGenitourinaryGestationGigantismGiardiasisGiantismGingiva
Other Tagspandemic 2pandemic 3pandemic 4pandemic 5pandemic 6pandemic 7pandemic 8pandemic 9pandemic 10impending 2impending 3inner 2inner 3inner 4inner 5inner 6relatives 2relatives 3relatives 4sharing 2sharing 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |